Overview

To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To Evaluate the efficacy of Z-338 in subjects with Functional Dyspepsia, focusing on the assessment of subjective symptoms in order to further determine the optimal dosage and efficacy parameters for PhaseIII clinical trials.
Phase:
Phase 2
Details
Lead Sponsor:
Zeria Pharmaceutical
Treatments:
Z 338